159
For Medical Staff
Table 205 – Recommended separation distances between portable and mobile RF communications equipment and the
EQUIPMENT or SYSTEM – for IEC 60601-1-2:2007 (EN 60601-1-2:2007)
for LIFESUPPORTING EQUIPMENT and SYSTEMS (see 5.2.2.2)
Recommended separation distances between portable and mobile RF communications
equipment and the TERUFUSION Syringe Pump Type SS3 OTCI
The TERUFUSION Syringe Pump Type SS3 OTCI is intended for use in an electromagnetic environment in which radiated RF
disturbances are controlled. The customer or the user of the TERUFUSION Syringe Pump Type SS3 OTCI can help prevent
electromagnetic interference by maintaining a minimum distance between portable and mobile RF communications equipment
(transmitters) and the TERUFUSION Syringe Pump Type SS3 OTCI as recommended below, according to the maximum output
power of the communications equipment.
Separation distance according to frequency of transmitter
m
Rated maximum output
power of transmitter
W
150 kHz to 80 MHz
outside ISM bands
d=1.2
√
P
150 kHz to 80 MHz in
ISM bands
d=1.2
√
P
80 MHz to 800 MHz
d=1.2
√
P
800 MHz to 2.5 GHz
d=2.3
√
P
0.01
0.12
0.12
0.12
0.23
0.1
0.38
0.38
0.38
0.73
1
1.2
1.2
1.2
2.3
10
3.8
3.8
3.8
7.3
100
12
12
12
23
For transmitters rated at a maximum output power not listed above, the recommended separation distance d in metres (m) can
be determined using the equation applicable to the frequency of the transmitter, where P is the maximum output power rating of
the transmitter in watts (W) according to the transmitter manufacturer.
Notes
1. At 80 MHz and 800 MHz, the separation distance for the higher frequency range applies.
2. The ISM (industrial, scientific and medical) bands between 150 kHz and 80 MHz are 6.765 MHz to 6.795 MHz; 13.553 MHz
to 13.567 MHz; 26.957 MHz to 27.283 MHz; and 40.66 MHz to 40.70 MHz.
3. An additional factor of 10/3 is used in calculating the recommended separation distance for transmitters in the ISM
frequency bands between 150 kHz and 80 MHz and in the frequency range 80 MHz to 2.5 GHz to decrease the likelihood
that mobile/portable communications equipment could cause interference if it is inadvertently brought into patient areas.
4. These guidelines may not apply in all situations. Electromagnetic propagation is affected by absorption and reflection from
structures, objects and people.
Table a) – Manufacturer’s declaration – electromagnetic emissions – for IEC 60601-1-2:2014 (EN 60601-1-2:2015)
Manufacturer’s declaration - electromagnetic emissions
The TERUFUSION Syringe Pump Type SS3 OTCI is intended for use in the electromagnetic environment specified below. The
customer or the user of the TERUFUSION Syringe Pump Type SS3 OTCI should assure that it is used in such an environment.
Emissions test
Emissions class and group
RF emissions
CISPR 11
Group 1
RF emissions
CISPR 11
Class [A]*
Harmonic emissions
IEC 61000-3-2
Class [A]
Voltage fluctuations / flicker emissions
IEC 61000-3-3
Complies
* The EMISSIONS characteristics of this equipment make it suitable for use in industrial areas and hospitals (CISPR 11 class A). If
it is used in a residential environment (for which CISPR 11 class B is normally required) this equipment might not offer adequate
protection to radiofrequency communication services. The user might need to take mitigation measures, such as relocating or
re-orienting the equipment.
Summary of Contents for TERUFUSION TE-SS830P
Page 163: ...163 Memo ...
